Innovative Research Award
| Maryam Ranjpour | |
|---|---|
| Researcher | Maryam Ranjpour |
| Affiliation | University of Texas Health Science Center at Tyler |
| Country | United States |
| Google Scholar ID | Profile |
| Citations | 86 |
| h-index | 6 |
| Subject Area | Drug Delivery Systems, Cardiovascular Research, Translational Medicine |
| Event | Botany Scientist Awards |
The Maryam Ranjpour recognizes distinguished academic and scientific contributions associated with translational medicine, cardiovascular investigation, and advanced drug delivery systems. Maryam Ranjpour has been identified for scholarly activities involving interdisciplinary biomedical research, publication development, and collaborative scientific engagement within applied medical sciences. The recognition is presented within the framework of the Botany Scientist Awards, highlighting academic excellence, research visibility, and measurable scientific impact through citations and scholarly dissemination.
Abstract
This academic recognition article summarizes the research profile and scholarly relevance of Maryam Ranjpour in relation to the Innovative Research Award. The documented academic activities emphasize multidisciplinary biomedical investigation, particularly within drug delivery systems, cardiovascular science, and translational medical methodologies. Citation metrics, publication visibility, and subject-area engagement collectively indicate an active research trajectory aligned with emerging healthcare technologies and evidence-based clinical applications.[2]
Keywords
Innovative Research Award, Maryam Ranjpour, Drug Delivery Systems, Cardiovascular Research, Translational Medicine, Biomedical Sciences, Scientific Publications, Research Impact, Academic Recognition, Citation Analysis.
Introduction
Contemporary biomedical research increasingly depends on interdisciplinary collaboration and translational methodologies capable of connecting laboratory findings with clinical implementation. Within this context, the Innovative Research Award acknowledges researchers whose scholarly contributions demonstrate measurable relevance to evolving healthcare challenges. Maryam Ranjpour’s research profile reflects participation in scientific domains associated with advanced therapeutic systems, medical technologies, and cardiovascular investigation.[3]
Research Profile
Maryam Ranjpour is affiliated with the University of Texas Health Science Center at Tyler in the United States. The research profile associated with this affiliation demonstrates involvement in biomedical and translational scientific investigations. Current academic metrics indicate a citation count of 86 and an h-index of 6, reflecting measurable scholarly engagement within the scientific literature.
Research Contributions
Research contributions associated with Maryam Ranjpour involve scientific themes related to translational biomedical applications and therapeutic innovation. Investigations within drug delivery systems often focus on optimizing pharmacological efficiency, improving bioavailability, and supporting targeted therapeutic delivery. Such research contributes to broader scientific objectives aimed at enhancing patient outcomes and clinical reliability.[6]
Publications
The publication profile associated with Maryam Ranjpour reflects participation in peer-reviewed scientific dissemination related to biomedical and translational healthcare research. Scholarly publications serve as an essential mechanism for communicating experimental findings, validating methodologies, and contributing to cumulative scientific knowledge.[2]
Research Impact
Research impact is commonly evaluated through citation activity, publication visibility, interdisciplinary collaboration, and academic influence within specialized scientific communities. The citation metrics associated with Maryam Ranjpour indicate ongoing scholarly engagement and measurable recognition within biomedical literature.
Award Suitability
The Innovative Research Award recognizes academic professionals whose work demonstrates scientific relevance, interdisciplinary engagement, and measurable scholarly contribution. Maryam Ranjpour’s documented activities in translational medicine and biomedical sciences align with the objectives commonly associated with innovation-oriented academic recognition programs.[3]
Conclusion
Maryam Ranjpour’s scholarly profile demonstrates engagement in biomedical and translational research areas associated with healthcare innovation and therapeutic advancement. Academic metrics including citation activity and interdisciplinary publication involvement contribute to the relevance of the Innovative Research Award recognition. The presented profile reflects a research trajectory connected to scientific collaboration, medical application, and ongoing academic dissemination within contemporary biomedical sciences.
External Links
References
- National Center for Biotechnology Information. (2021). Biomedical publication indexing and translational medicine resources.https://pubmed.ncbi.nlm.nih.gov/
- World Health Organization. (2023). Innovation and translational approaches in global healthcare systems.https://www.who.int/
- Elevated Expression of A-Raf and FA2H in Hepatocellular Carcinoma is Associated with Lipid Metabolism Dysregulation and Cancer Progression, https://doi.org/10.2174/1871520618666181015142810
- Elevated expression of cellular SYNE1, MMP10, and GTPase1 and their regulatory role in hepatocellular carcinoma progression.https://doi.org/10.1016/j.addr.2020.11.002
- Novel mutations in transthyretin gene associated with hepatocellular carcinoma, https://doi.org/10.1002/mc.22732